397 related articles for article (PubMed ID: 11268450)
1. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast.
Wang HC; Sun SS; Kao A; Lin CC; Lee CC
Cancer Invest; 2002; 20(3):318-23. PubMed ID: 12025226
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts.
Yang MD; Sun SS; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(4):518-23. PubMed ID: 12094547
[TBL] [Abstract][Full Text] [Related]
4. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
5. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of thallium-201 SPECT scintimammography to differentiate benign from malignant breast masses in mammographically dense breasts.
Chiou JF; Lin MC; Chen DR; Jim YF; Kao CH
Cancer Invest; 2003; 21(6):863-8. PubMed ID: 14735690
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
9. A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast.
Chen YS; Wang WH; Chan T; Sun SS; Kao A
Surg Oncol; 2002 Nov; 11(3):151-5. PubMed ID: 12356511
[TBL] [Abstract][Full Text] [Related]
10. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m sestamibi scintimammography in the mammographically dense breast.
Zegel H; Heller L; Edell S; Squires F; Rubin J
Clin Nucl Med; 1999 Dec; 24(12):968-74. PubMed ID: 10595479
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
[TBL] [Abstract][Full Text] [Related]
13. The role of scintimammography with 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer.
Danielsson R; Reihnér E; Grabowska A; Boné B
Acta Radiol; 2000 Sep; 41(5):441-5. PubMed ID: 11016763
[TBL] [Abstract][Full Text] [Related]
14. New method for breast cancer detection using TC-99m sestamibi scintimammography.
Yuen-Green M; Wasnich R; Caindec-Ranchez S; Davis J
Hawaii Med J; 1996 Feb; 55(2):26-8. PubMed ID: 8820628
[TBL] [Abstract][Full Text] [Related]
15. Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
Uriarte I; Carril JM; Quirce R; Gutiérrez-Mendiguchía C; Blanco I; Banzo I; Vega A; Hernández A
Eur J Nucl Med; 1998 May; 25(5):491-6. PubMed ID: 9575244
[TBL] [Abstract][Full Text] [Related]
16. (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study.
Khalkhali I; Baum JK; Villanueva-Meyer J; Edell SL; Hanelin LG; Lugo CE; Taillefer R; Freeman LM; Neal CE; Scheff AM; Connolly JL; Schnitt SJ; Houlihan MJ; Sampalis JS; Haber SB
Radiology; 2002 Jan; 222(1):149-55. PubMed ID: 11799940
[TBL] [Abstract][Full Text] [Related]
17. 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer.
Rajkovaca Z; Vuleta G; Matavulj A; Kovacević P; Ponorac N
Bosn J Basic Med Sci; 2007 Aug; 7(3):256-60. PubMed ID: 17848153
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
Gutfilen B; Fonseca LM
J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219
[TBL] [Abstract][Full Text] [Related]
20. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
